Genetics/Genomics News

Results from a survey of the American public indicated that clinicians should be involved in analyzing genetic test results.

In a large genome-wide association study, a genetic variant predisposing to CAD was identified on the short arm of chromosome 6 (6p21.3).

Carriers of the apolipoprotein E epsilon 4 allele are more likely to experience long-term cognitive decline 5 years after cardiac surgery than noncarriers, according to research presented at the American Society of Anesthesiologists’ annual meeting.

AMSTERDAM — Losartan, an angiotensin II receptor antagonist, reduced the rate of aortic enlargement in patients with Marfan syndrome, according to data presented at ESC Congress 2013.

AMSTERDAM — Losartan, an angiotensin II receptor antagonist, reduced the rate of aortic enlargement in patients with Marfan syndrome, according to data presented at ESC Congress 2013.

A research team has identified a genetic variant, rs10911021 on chromosome 1q25, that is strongly associated with risk for CHD in patients with type 2 diabetes.

Spartan Bioscience announced that it has received FDA clearance for a rapid genetic testing device that identifies variants in the CYP2C19 gene.

A Mediterranean diet counteracted the effects of a gene variant associated with type 2 diabetes and reduced the risk for stroke in people with two copies of the variant, according to new data from the PREDIMED study.

Mutations in the gene KCNK3 that affect potassium channels in the pulmonary artery have been linked to familial and idiopathic pulmonary arterial hypertension, and some of the effects may be counteracted with a phospholipase inhibitor, according to new study findings.